Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

Vaxart, Inc. (NASDAQ:VXRT), a biotechnology company specializing in the development of oral recombinant vaccines with a market capitalization of approximately $159 million, announced on Monday an ...

Ocean Biomedical intends to leverage this opportunity ... Kurtis secured an additional $3.5 million NIH grant to further identify vaccine targets to protect against severe malaria in children.

Our problem is that in our zeal to prompt parents to do the right thing, we have assailed their credibility instead of ...

Ocean Biomedical announced that Dr. Jonathan Kurtis and his team have secured significant funding from the NIH to advance their malaria vaccine research, which focuses on a unique protein found on ...

Building on clinical data from millions of individuals who received lipid-encapsulated mRNA vaccines, the FDA has issued new guidance that could facilitate a faster transition to first-in-human trials ...

We look forward to further exploring the GARP pathway to develop a vaccine that could have a transformative impact on global health.” Ocean Biomedical, Inc. is a Providence, Rhode Island-based ...